169 related articles for article (PubMed ID: 25602514)
1. Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.
Escudero P; Martinez de Marañón A; Collado A; Gonzalez-Navarro H; Hermenegildo C; Peiró C; Piqueras L; Sanz MJ
Antioxid Redox Signal; 2015 Apr; 22(11):901-20. PubMed ID: 25602514
[TBL] [Abstract][Full Text] [Related]
2. Retinoid X receptor agonists impair arterial mononuclear cell recruitment through peroxisome proliferator-activated receptor-γ activation.
Sanz MJ; Albertos F; Otero E; Juez M; Morcillo EJ; Piqueras L
J Immunol; 2012 Jul; 189(1):411-24. PubMed ID: 22661092
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis.
Escudero P; Navarro A; Ferrando C; Furio E; Gonzalez-Navarro H; Juez M; Sanz MJ; Piqueras L
Br J Pharmacol; 2015 Jun; 172(12):2946-60. PubMed ID: 25630951
[TBL] [Abstract][Full Text] [Related]
4. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II.
Rius C; Piqueras L; González-Navarro H; Albertos F; Company C; López-Ginés C; Ludwig A; Blanes JI; Morcillo EJ; Sanz MJ
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):96-104. PubMed ID: 23117657
[TBL] [Abstract][Full Text] [Related]
5. Activation of the retinoid X receptor modulates angiotensin II-induced smooth muscle gene expression and inflammation in vascular smooth muscle cells.
Lehman AM; Montford JR; Horita H; Ostriker AC; Weiser-Evans MC; Nemenoff RA; Furgeson SB
Mol Pharmacol; 2014 Nov; 86(5):570-9. PubMed ID: 25169989
[TBL] [Abstract][Full Text] [Related]
6. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
Abu Nabah YN; Losada M; Estellés R; Mateo T; Company C; Piqueras L; Lopez-Gines C; Sarau H; Cortijo J; Morcillo EJ; Jose PJ; Sanz MJ
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2370-6. PubMed ID: 17717298
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines.
Mateo T; Abu Nabah YN; Abu Taha M; Mata M; Cerdá-Nicolás M; Proudfoot AE; Stahl RA; Issekutz AC; Cortijo J; Morcillo EJ; Jose PJ; Sanz MJ
J Immunol; 2006 May; 176(9):5577-86. PubMed ID: 16622027
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
Li Y; Wang Q; Zhou J; Xu Q; Chu X; Sun T; Liu X; Cai S
Eur J Pharmacol; 2014 Jan; 723():23-8. PubMed ID: 24333476
[TBL] [Abstract][Full Text] [Related]
9. Bexarotene, a Selective RXRα Agonist, Reverses Hypotension Associated with Inflammation and Tissue Injury in a Rat Model of Septic Shock.
Tunctan B; Kucukkavruk SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S
Inflammation; 2018 Feb; 41(1):337-355. PubMed ID: 29188497
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
Kang BY; Mehta JL
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin improves endothelial function in db/db mice: role of angiotensin II type 1 receptors and oxidative stress.
Tian XY; Wong WT; Xu A; Chen ZY; Lu Y; Liu LM; Lee VW; Lau CW; Yao X; Huang Y
Br J Pharmacol; 2011 Sep; 164(2b):598-606. PubMed ID: 21486274
[TBL] [Abstract][Full Text] [Related]
13. Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium.
Rius C; Company C; Piqueras L; Cerdá-Nicolás JM; González C; Servera E; Ludwig A; Morcillo EJ; Sanz MJ
Thorax; 2013 Feb; 68(2):177-86. PubMed ID: 23143793
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.
van der Harst P; Groenewegen HC; Roks AJ; Buikema H; Zijlstra F; van Gilst WH; de Smet BJ
Coron Artery Dis; 2008 Feb; 19(1):47-53. PubMed ID: 18281816
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of leukocyte recruitment to the atheroprone femoral artery reveals anti-inflammatory effects of rosuvastatin.
Osaka M; Hagita S; Yoshida M
Biomed Res Int; 2013; 2013():962369. PubMed ID: 23509822
[TBL] [Abstract][Full Text] [Related]
16. [Effects and related mechanism of retinoid X receptor agonist bexarotene on atherosclerosis progression in diabetic apoE(-/-) mice].
Zhu J; Xu C; Ning R; Chai D; Lin J
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):492-7. PubMed ID: 25164224
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation.
Pignatelli P; Carnevale R; Di Santo S; Bartimoccia S; Nocella C; Vicario T; Loffredo L; Angelico F; Violi F
Biochem Pharmacol; 2012 Dec; 84(12):1635-42. PubMed ID: 23022230
[TBL] [Abstract][Full Text] [Related]
18. A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles.
Mateo T; Naim Abu Nabah Y; Losada M; Estellés R; Company C; Bedrina B; Cerdá-Nicolás JM; Poole S; Jose PJ; Cortijo J; Morcillo EJ; Sanz MJ
Blood; 2007 Sep; 110(6):1895-902. PubMed ID: 17595330
[TBL] [Abstract][Full Text] [Related]
19. L-NAME induces direct arteriolar leukocyte adhesion, which is mainly mediated by angiotensin-II.
Nabah YN; Mateo T; Cerdá-Nicolás M; Alvarez A; Martinez M; Issekutz AC; Sanz MJ
Microcirculation; 2005; 12(5):443-53. PubMed ID: 16020392
[TBL] [Abstract][Full Text] [Related]
20. Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in rats.
De Ciuceis C; Amiri F; Iglarz M; Cohn JS; Touyz RM; Schiffrin EL
Br J Pharmacol; 2007 May; 151(1):45-53. PubMed ID: 17351653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
